A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice
We developed a bacterial expression system to produce a recombinant disintegrin, vicrostatin (VCN), whose structure is based on a natural disintegrin isolated from southern copperhead snake venom. Our goal is to develop VCN for potential clinical translation as an anti-cancer agent. VCN is a peptide...
Main Authors: | Steve Swenson, Radu O. Minea, Cao Duc Tuan, Thu-Zan Thein, Thomas C. Chen, Francis S. Markland |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/23/11/2918 |
Similar Items
-
Recombinant and Chimeric Disintegrins in Preclinical Research
by: Victor David, et al.
Published: (2018-08-01) -
Snake venom metalloproteinases and disintegrins: interactions with cells
by: Kamiguti A.S., et al.
Published: (1998-01-01) -
Disintegrins from the venom of Vipera ammodytes ammodytes efficiently inhibit migration of breast cancer cells
by: Zorica Latinović, et al.
Published: (2017-09-01) -
Snake Venom Metalloproteinases (SVMPs): A structure-function update
by: Olamide Tosin Olaoba, et al.
Published: (2020-09-01) -
Snake Venom Disintegrins and Cell Migration
by: Heloisa S. Selistre-de-Araujo, et al.
Published: (2010-10-01)